Literature DB >> 5571839

A study of two methods for estimating plasma fibrinogen and the effect of epsilon aminocaproic acid and protamine.

J C Giddings, A L Bloom.   

Abstract

Fibrinogen concentrations were determined in normal plasma and in plasma from patients with high and low levels. There was a good correlation between the results of a rapid semi-quantitative fibrinogen titre technique and those of a quantitative assay of coagulable fibrinogen. In normal subjects fibrinogen levels were not significantly influenced by taking blood into epsilon aminocaproic acid (EACA) or by the addition of protamine to plasma. In patients with the defibrination syndrome in whom increased plasma fibrinolysis was not detected, fibrinogen levels were not affected by taking blood into EACA but considerably increased levels were observed after the addition of protamine to plasma. In patients undergoing thrombolytic therapy the fibrinogen levels measured were increased both in blood taken into EACA and in plasma containing protamine. It is suggested that EACA acted by preventing lysis in vitro whilst protamine counteracted abnormal fibrin polymerization. The pattern of results may be of diagnostic importance.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5571839      PMCID: PMC477029          DOI: 10.1136/jcp.24.5.467

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  HAEMATOLOGY AND THE EXTRACORPOREAL CIRCULATION.

Authors:  A A SHARP; M J EGGLETON
Journal:  J Clin Pathol       Date:  1963-11       Impact factor: 3.411

2.  THE ESTIMATION OF FIBRINOGEN. A REVISION.

Authors:  T ASTRUP; P BRAKMAN; U NISSEN
Journal:  Scand J Clin Lab Invest       Date:  1965       Impact factor: 1.713

3.  Determination of fibrinogen and fibrinogenolytic activity.

Authors:  I M NILSSON; B OLOW
Journal:  Thromb Diath Haemorrh       Date:  1962-11-15

4.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

5.  Defibrination syndrome in pregnancy: value of various diagnostic tests.

Authors:  A A SHARP; B HOWIE; R BIGGS; D T METHUEN
Journal:  Lancet       Date:  1958-12-20       Impact factor: 79.321

6.  The determination of plasma fibrinogen by turbidity with ammonium sulfate.

Authors:  I A PARFENTJEV; M L JOHNSON; E E CLIFFTON
Journal:  Arch Biochem Biophys       Date:  1953-10       Impact factor: 4.013

7.  A new method for the determination of fibrinogen in small samples of plasma.

Authors:  O D RATNOFF; C MENZIE
Journal:  J Lab Clin Med       Date:  1951-02

8.  Defibrination syndrome with defective thrombinfibrinogen reaction reversible by protamine.

Authors:  A L Bloom; N Campbell
Journal:  J Clin Pathol       Date:  1965-11       Impact factor: 3.411

9.  Significance of cryoprofibrin in fibrinogen-fibrin conversion.

Authors:  J R SHAINOFF; I H PAGE
Journal:  J Exp Med       Date:  1962-11-01       Impact factor: 14.307

  9 in total
  3 in total

1.  Physical and biological characterization of ferromagnetic fiber networks: effect of fibrin deposition on short-term in vitro responses of human osteoblasts.

Authors:  Rose L Spear; Brajith Srigengan; Suresh Neelakantan; Wolfram Bosbach; Roger A Brooks; Athina E Markaki
Journal:  Tissue Eng Part A       Date:  2014-10-03       Impact factor: 3.845

2.  The production and testing of staphylococci with clumping factor activity for use in the assay of fibrinogen degradation products.

Authors:  G Richardson
Journal:  J Clin Pathol       Date:  1973-05       Impact factor: 3.411

3.  Fibrin concentration affects ACL fibroblast proliferation and collagen synthesis.

Authors:  Patrick Vavken; Shilpa M Joshi; Martha M Murray
Journal:  Knee       Date:  2010-01-18       Impact factor: 2.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.